janus faced course of covid-19 infection in patients with hematological malignancies. This article is protected by copyright. All rights reserved.The COVID-19 pandemic affects most countries of the world resulting in significant morbidity and mortality from this infection with SARS-CoV2 (1). It was reported that among others specifically patients with cancer (including patients with hematological malignancies) are at a higher risk for severe and fatal infection (2). Here, we report three consecutive patients with underlying hematologic malignancies and co-morbidities who were admitted to the infectious diseases ward at our department because of SARS-CoV2 infection.